#Efficacy of Cognitive Rehabilitation in Alzheimer Disease: A 1-Year Follow-Up Study
1	1	0	8	Efficacy
1	2	9	11	of
1	3	12	21	Cognitive
1	4	22	36	Rehabilitation
1	5	37	39	in
1	6	40	49	Alzheimer
1	7	50	57	Disease
1	8	57	58	:
1	9	59	60	A
1	10	61	67	1-Year
1	11	68	77	Follow-Up
1	12	78	83	Study
#INTRODUCTION: The benefit of cognitive rehabilitation (CR) for patients with early-stage Alzheimer disease (AD) remains difficult to assess.
2	1	84	96	INTRODUCTION
2	2	96	97	:
2	3	98	101	The
2	4	102	109	benefit
2	5	110	112	of
2	6	113	122	cognitive
2	7	123	137	rehabilitation
2	8	138	139	(
2	9	139	141	CR
2	10	141	142	)
2	11	143	146	for
2	12	147	155	patients
2	13	156	160	with
2	14	161	172	early-stage
2	15	173	182	Alzheimer
2	16	183	190	disease
2	17	191	192	(
2	18	192	194	AD
2	19	194	195	)
2	20	196	203	remains
2	21	204	213	difficult
2	22	214	216	to
2	23	217	223	assess
2	24	223	224	.
#METHOD: An observational, prospective study was conducted in a sample of 52 patients with AD included in a clinical, individualized CR program.
3	1	366	372	METHOD
3	2	372	373	:
3	3	374	376	An
3	4	377	390	observational
3	5	390	391	,
3	6	392	403	prospective
3	7	404	409	study
3	8	410	413	was
3	9	414	423	conducted
3	10	424	426	in
3	11	427	428	a
3	12	429	435	sample
3	13	436	438	of
3	14	439	441	52
3	15	442	450	patients
3	16	451	455	with
3	17	456	458	AD
3	18	459	467	included
3	19	468	470	in
3	20	471	472	a
3	21	473	481	clinical
3	22	481	482	,
3	23	483	497	individualized
3	24	498	500	CR
3	25	501	508	program
3	26	508	509	.
#Cognitive rehabilitation consisted of 1 weekly session during 3 months at home, followed by 1 monthly contact for 9 months.
4	1	654	663	Cognitive
4	2	664	678	rehabilitation
4	3	679	688	consisted
4	4	689	691	of
4	5	692	693	1
4	6	694	700	weekly
4	7	701	708	session
4	8	709	715	during
4	9	716	717	3
4	10	718	724	months
4	11	725	727	at
4	12	728	732	home
4	13	732	733	,
4	14	734	742	followed
4	15	743	745	by
4	16	746	747	1
4	17	748	755	monthly
4	18	756	763	contact
4	19	764	767	for
4	20	768	769	9
4	21	770	776	months
4	22	776	777	.
#Rehabilitation techniques were used by experienced therapists to adapt activities important for the patient.
5	1	902	916	Rehabilitation
5	2	917	927	techniques
5	3	928	932	were
5	4	933	937	used
5	5	938	940	by
5	6	941	952	experienced
5	7	953	963	therapists
5	8	964	966	to
5	9	967	972	adapt
5	10	973	983	activities
5	11	984	993	important
5	12	994	997	for
5	13	998	1001	the
5	14	1002	1009	patient
5	15	1009	1010	.
#Evaluation of patient's dependence in activities and objective and subjective caregiver's burden was performed with a research quantitative scale immediately after the intervention and at 6-month and 1-year follow-up.
6	1	1120	1130	Evaluation
6	2	1131	1133	of
6	3	1134	1141	patient
6	4	1141	1143	's
6	5	1144	1154	dependence
6	6	1155	1157	in
6	7	1158	1168	activities
6	8	1169	1172	and
6	9	1173	1182	objective
6	10	1183	1186	and
6	11	1187	1197	subjective
6	12	1198	1207	caregiver
6	13	1207	1209	's
6	14	1210	1216	burden
6	15	1217	1220	was
6	16	1221	1230	performed
6	17	1231	1235	with
6	18	1236	1237	a
6	19	1238	1246	research
6	20	1247	1259	quantitative
6	21	1260	1265	scale
6	22	1266	1277	immediately
6	23	1278	1283	after
6	24	1284	1287	the
6	25	1288	1300	intervention
6	26	1301	1304	and
6	27	1305	1307	at
6	28	1308	1315	6-month
6	29	1316	1319	and
6	30	1320	1326	1-year
6	31	1327	1336	follow-up
6	32	1336	1337	.
#RESULTS: Analyses with repeated measure analysis of variance showed decreased patient's dependence for adapted activities at 3 months, 6 months, and 1 year.
7	1	1556	1563	RESULTS
7	2	1563	1564	:
7	3	1565	1573	Analyses
7	4	1574	1578	with
7	5	1579	1587	repeated
7	6	1588	1595	measure
7	7	1596	1604	analysis
7	8	1605	1607	of
7	9	1608	1616	variance
7	10	1617	1623	showed
7	11	1624	1633	decreased
7	12	1634	1641	patient
7	13	1641	1643	's
7	14	1644	1654	dependence
7	15	1655	1658	for
7	16	1659	1666	adapted
7	17	1667	1677	activities
7	18	1678	1680	at
7	19	1681	1682	3
7	20	1683	1689	months
7	21	1689	1690	,
7	22	1691	1692	6
7	23	1693	1699	months
7	24	1699	1700	,
7	25	1701	1704	and
7	26	1705	1706	1
7	27	1707	1711	year
7	28	1711	1712	.
#Objective and subjective percentage of caregiver's burden was also decreased at all evaluations with our research functional scale, while there was no change on Zarit's burden scale.
8	1	1870	1879	Objective
8	2	1880	1883	and
8	3	1884	1894	subjective
8	4	1895	1905	percentage
8	5	1906	1908	of
8	6	1909	1918	caregiver
8	7	1918	1920	's
8	8	1921	1927	burden
8	9	1928	1931	was
8	10	1932	1936	also
8	11	1937	1946	decreased
8	12	1947	1949	at
8	13	1950	1953	all
8	14	1954	1965	evaluations
8	15	1966	1970	with
8	16	1971	1974	our
8	17	1975	1983	research
8	18	1984	1994	functional
8	19	1995	2000	scale
8	20	2000	2001	,
8	21	2002	2007	while
8	22	2008	2013	there
8	23	2014	2017	was
8	24	2018	2020	no
8	25	2021	2027	change
8	26	2028	2030	on
8	27	2031	2036	Zarit
8	28	2036	2038	's
8	29	2039	2045	burden
8	30	2046	2051	scale
8	31	2051	2052	.
#Global cognition slightly decreased over 1 year.
9	1	2236	2242	Global
9	2	2243	2252	cognition
9	3	2253	2261	slightly
9	4	2262	2271	decreased
9	5	2272	2276	over
9	6	2277	2278	1
9	7	2279	2283	year
9	8	2283	2284	.
#CONCLUSIONS: This observational study in a clinical setting is in line with the benefit of CR for patients with mild AD reported in recent randomized controlled trials.
10	1	2334	2345	CONCLUSIONS
10	2	2345	2346	:
10	3	2347	2351	This
10	4	2352	2365	observational
10	5	2366	2371	study
10	6	2372	2374	in
10	7	2375	2376	a
10	8	2377	2385	clinical
10	9	2386	2393	setting
10	10	2394	2396	is
10	11	2397	2399	in
10	12	2400	2404	line
10	13	2405	2409	with
10	14	2410	2413	the
10	15	2414	2421	benefit
10	16	2422	2424	of
10	17	2425	2427	CR
10	18	2428	2431	for
10	19	2432	2440	patients
10	20	2441	2445	with
10	21	2446	2450	mild
10	22	2451	2453	AD
10	23	2454	2462	reported
10	24	2463	2465	in
10	25	2466	2472	recent
10	26	2473	2483	randomized
10	27	2484	2494	controlled
10	28	2495	2501	trials
10	29	2501	2502	.
#The benefit obtained for adapted activities remained after 1 year, even if global cognition declined.
11	1	2672	2675	The
11	2	2676	2683	benefit
11	3	2684	2692	obtained
11	4	2693	2696	for
11	5	2697	2704	adapted
11	6	2705	2715	activities
11	7	2716	2724	remained
11	8	2725	2730	after
11	9	2731	2732	1
11	10	2733	2737	year
11	11	2737	2738	,
11	12	2739	2743	even
11	13	2744	2746	if
11	14	2747	2753	global
11	15	2754	2763	cognition
11	16	2764	2772	declined
11	17	2772	2773	.
#Moreover caregiver's burden related to all individually relevant daily activities (from a list of 98) evaluated within the CR program was decreased after 1 year.
12	1	2876	2884	Moreover
12	2	2885	2894	caregiver
12	3	2894	2896	's
12	4	2897	2903	burden
12	5	2904	2911	related
12	6	2912	2914	to
12	7	2915	2918	all
12	8	2919	2931	individually
12	9	2932	2940	relevant
12	10	2941	2946	daily
12	11	2947	2957	activities
12	12	2958	2959	(
12	13	2959	2963	from
12	14	2964	2965	a
12	15	2966	2970	list
12	16	2971	2973	of
12	17	2974	2976	98
12	18	2976	2977	)
12	19	2978	2987	evaluated
12	20	2988	2994	within
12	21	2995	2998	the
12	22	2999	3001	CR
12	23	3002	3009	program
12	24	3010	3013	was
12	25	3014	3023	decreased
12	26	3024	3029	after
12	27	3030	3031	1
12	28	3032	3036	year
12	29	3036	3037	.
#Those preliminary results emphasize the importance of choice for the measurement instrument to report CR efficacy and claim for further validation of such tools.
13	1	3200	3205	Those
13	2	3206	3217	preliminary
13	3	3218	3225	results
13	4	3226	3235	emphasize
13	5	3236	3239	the
13	6	3240	3250	importance
13	7	3251	3253	of
13	8	3254	3260	choice
13	9	3261	3264	for
13	10	3265	3268	the
13	11	3269	3280	measurement
13	12	3281	3291	instrument
13	13	3292	3294	to
13	14	3295	3301	report
13	15	3302	3304	CR
13	16	3305	3313	efficacy
13	17	3314	3317	and
13	18	3318	3323	claim
13	19	3324	3327	for
13	20	3328	3335	further
13	21	3336	3346	validation
13	22	3347	3349	of
13	23	3350	3354	such
13	24	3355	3360	tools
13	25	3360	3361	.
